All of a biotech's financial steering, in one place.
Designed so the executive keeps control without spending their days on it. From the starting assumption to board reporting, Redmontis replaces the patchwork of spreadsheets with a single, traceable dataset shared with your CFO.
Native FP&A modeling
A model structure built for the long cycles and discontinuous spending of R&D: milestones, trials, disbursements, regulatory gates.
Burn & runway in real time
The cash trajectory and the runway end date recalculate the moment an assumption changes. No more frozen version while you wait for an export.
Integrated clinical milestones
Link each milestone to its financial impact. A phase delay translates immediately into months of runway gained or lost.
Compared scenarios
R&D spending is entered in Gantt mode with linked tasks: shifting a milestone automatically moves the dependent tasks, without dragging everything by hand. That way you compare several trajectories side by side and decide in the meeting, not after.
Investor reporting
Generate readable, consistent reporting from the same dataset. A stable format from one board and one raise to the next.
Assumptions & traceability
A single source for the key drivers, with version history to defend every number in front of a board or an auditor.
From raw data to a defensible decision.
- Enter or import your key assumptions once
- See burn, runway and milestones on a single view
- Test scenarios without breaking the model
- Export board-ready reporting
The product, screen by screen.
The solution covers nine screens that all read the same base: change one assumption, and everything updates. Here are the main ones, as an executive or their CFO use them day to day.
Data from a fictional case, for demonstration purposes only
Dashboard
Runway, burn rate, cash, funding gap and next decision brought together on a single screen. The overall picture the CEO and CFO look at first.

Headcount
FTE, payroll, R&D share, JEI status and CIR generated, position by position and month by month.

Spending
R&D OPEX detailed by program (pre-clinical, CMC, clinical, business, G&A), entered in Gantt mode with linked tasks, according to your development plan.

Use of Proceeds
A Uses / Sources table linked to milestones, with funding needs and coverage. Board-ready.

A precise finance tool, not a generalist.
Redmontis is neither an accounting ERP, nor a clinical data tool, nor software for lab scientists. It is an instrument for the finance people who work in a demanding scientific environment.
Your financial data, treated as such.
Runway, fundraising scenarios, funding amounts: a biotech's most sensitive data. A system that meets the highest security standards.
Encryption
Data encrypted at rest (AES-256) and in transit (TLS 1.3).
Hosting & infrastructure
Supabase / AWS database, Vercel / AWS servers, GDPR compliance.
Per-client isolation
Multi-tenant partitioning (Row-Level Security): each client only sees their own data.
Audit & control
Logging of exports and shares, right to export and to delete.
A demo on your own numbers beats a product sheet.
We start from your clinical stage, your cost structure and your fundraising timeline.
Request a demoRedmontis is not just one more tool.
Each tool covers a slice. Redmontis is the only full column on runway, cash scenarios, CIR and clinical milestones linked to cash.
| Category | Examples | What it's for | Place in the financial stack |
|---|---|---|---|
| Spreadsheet | Excel + outsourced CFO | Financial modeling by hand | Bespoke, but fragile and untraceable |
| Business neobank | Qonto | Business account, payments, expenses | Banking and transactional layer |
| Online accounting | Dougs, Pennylane | Bookkeeping, filings | Accounting and reporting layer |
| Generalist FP&A | Anaplan, Pigment | Cross-industry financial modeling | Planning layer, all industries |
| Development planning | Scientific development software | Program, milestones, modalities | Scientific and operational layer |
| Biotech FP&A | Redmontis | Runway, cash scenarios, use of proceeds, CIR, milestones linked to cash | Biotech financial decision layer |
| Activity | Spreadsheet + CFO | Neobank | Online accounting | Generalist FP&A | Scientific planning | Redmontis |
|---|---|---|---|---|---|---|
| Track cash in real time | ~ | ✓ | ~ | ✗ | ✗ | ✓ |
| Keep the books and filings | ~ | ~ | ✓ | ✗ | ✗ | ✗ |
| Calculate runway and the cash-to-zero date | ~ | ✗ | ✗ | ~ | ~ | ✓ |
| Compare cash scenarios | ~ | ✗ | ✗ | ✓ | ~ | ✓ |
| Link use of proceeds to milestones | ~ | ✗ | ✗ | ~ | ✗ | ✓ |
| Integrate CIR, CIFRE and grants | ~ | ✗ | ~ | ✗ | ✗ | ✓ |
| Link clinical milestones to cash | ✗ | ✗ | ✗ | ✗ | ~ | ✓ |
| Produce biotech board and investor reporting | ~ | ✗ | ✗ | ~ | ~ | ✓ |
✓ covered ~ partial or manual ✗ not covered. Statutory accounting deliberately stays with the chartered accountant: Redmontis complements it, it does not replace it.
Competitive moat. The only steering tool that natively integrates the French CIR, CIFRE and grants (article 244 quater B of the CGI). A horizontal tool adapts to every industry, and fits none of them fully — least of all yours.
Not a neobank.Redmontis does not hold your account. It steers your runway.
Not accounting software.It replaces neither Dougs, nor Pennylane, nor your chartered accountant.
Not a generalist tool.No blank page like Anaplan or Pigment, and no enterprise-scale cost.
Not a scientific planner.It does not design your program. It funds the trajectory.



Five steps, from input to decision.
You enter your data once. Everything else updates, reads and simulates on its own.
Parameters & assumptions
You enter your key parameters and assumptions.
Spending & funding
You enter payroll costs, operating expenses in a Gantt view, raises and grants.
Cash & runway
You immediately read the cash position and the runway.
Funding need
You assess the funding need over the period, via the Use of Proceeds.
Scenario simulation
You simulate scenarios, with automatic shifting of all linked tasks (Gantt view).